| scholarly article | Q13442814 |
| P2093 | author name string | Jing Zhang | |
| Peng Gao | |||
| Hailong Lin | |||
| P2860 | cites work | Metabolomics reveals unique and shared metabolic changes in response to heat shock, freezing and desiccation in the Antarctic midge, Belgica antarctica | Q28271049 |
| Lysophosphatidylcholine transcriptionally induces growth factor gene expression in cultured human endothelial cells | Q34128848 | ||
| Silent myocardial ischemia | Q35214997 | ||
| Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells | Q35822759 | ||
| Metabonomics: systems biology in pharmaceutical research and development | Q35841301 | ||
| Metabolomics for phytomedicine research and drug development | Q37079380 | ||
| Metabolic profiling as a tool for understanding mechanisms of toxicity | Q37109101 | ||
| Should silent ischemia be treated in asymptomatic individuals? | Q37950536 | ||
| Phosphatidylcholine metabolism in ischemic and hypoxic hearts | Q38470223 | ||
| Prognostic importance of silent ischemia during long-term follow-up of patients with coronary artery disease. A short review based on own experience and current literature. | Q39717055 | ||
| Phospholipid lysophosphatidylcholine as a metabolic trigger and HERG as an ionic pathway for extracellular K accumulation and "short QT syndrome" in acute myocardial ischemia | Q40086847 | ||
| Quantitative exercise thallium-201 single photon emission computed tomography for the enhanced diagnosis of ischemic heart disease | Q41198155 | ||
| Significance of silent myocardial ischemia during exercise testing in patients with coronary artery disease | Q44099093 | ||
| Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics | Q44226354 | ||
| No effect of statin therapy on silent myocardial ischemia in patients with type 2 diabetes without manifest cardiovascular disease | Q46570722 | ||
| Metabolomic identification of novel biomarkers of myocardial ischemia | Q46847927 | ||
| Early diagnosis and exclusion of acute myocardial infarction using biochemical monitoring. The BIOMACS Study Group. Biochemicals Markers of Acute Coronary Syndromes | Q72011760 | ||
| Cytokine dysregulation induced by apoptotic cells is a shared characteristic of murine lupus | Q73086146 | ||
| Severity of coronary artery calcification by electron beam computed tomography predicts silent myocardial ischemia | Q73382038 | ||
| Lysophosphatidylcholine activates p38 and p42/44 mitogen-activated protein kinases in monocytic THP-1 cells, but only p38 activation is involved in its stimulated chemotaxis | Q73964054 | ||
| Silent myocardial ischemia in patients with stable coronary artery disease receiving conventional antianginal drug therapy | Q80163537 | ||
| P433 | issue | 1 | |
| P921 | main subject | silent myocardial ischemia | Q16644072 |
| P304 | page(s) | 45-50 | |
| P577 | publication date | 2009-01-01 | |
| P1433 | published in | Journal of Clinical Laboratory Analysis | Q15754724 |
| P1476 | title | Silent myocardial ischemia is associated with altered plasma phospholipids | |
| P478 | volume | 23 |
| Q37399610 | A Comparative Metabolomics Approach Reveals Early Biomarkers for Metabolic Response to Acute Myocardial Infarction |
| Q38066622 | A practical guide to metabolomic profiling as a discovery tool for human heart disease |
| Q47849940 | Apolipoprotein A-I mimetic peptide inhibits atherosclerosis by altering plasma metabolites in hypercholesterolemia |
| Q36607005 | Biomarkers intersect with the exposome |
| Q37943853 | Integration of metabolomics in heart disease and diabetes research: current achievements and future outlook |
| Q37700127 | Metabolomic Signature of Coronary Artery Disease in Type 2 Diabetes Mellitus |
| Q92602951 | Metabolomic characterization of myocardial ischemia-reperfusion injury in ST-segment elevation myocardial infarction patients undergoing percutaneous coronary intervention |
| Q57797380 | Metabolomics and Its Role in the Study of Mammalian Systems |
| Q59622191 | Metabolomics of diet-related diseases using mass spectrometry |
| Q26824720 | Metabolomics of oxidative stress in recent studies of endogenous and exogenously administered intermediate metabolites |
| Q37462435 | Metabolomics: moving to the clinic |
| Q51615648 | Proteomics and metabolomics in biomarker discovery for cardiovascular diseases: progress and potential. |
Search more.